Tirzepatide online access for Broken Arrow, Oklahoma
Company statements checked between September 10, 2026 and September 23, 2026: 2 covered companies — Gentle Health and GoodRx Care — advertise online access to Tirzepatide for patients in Oklahoma, including Broken Arrow. Confirm eligibility and total charges with the provider.
Browse online Tirzepatide programs advertised for patients in Broken Arrow, Oklahoma, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded injectable tirzepatide | $169/mo advertised monthly bundle, Compounded injectable tirzepatide | Official site ↗ | |
| GoodRx Care | Zepbound KwikPen | $338/mo partial monthly subtotal, Zepbound KwikPen | Official site ↗ |
Health context in Broken Arrow
Tirzepatide programs are marketed for weight management and, for some products, type 2 diabetes. These Broken Arrow figures give local context only. Among the 5 Oklahoma cities in this research set, Broken Arrow has the tied for lowest estimate for routine checkup in the past year among adults (75.8%).
| Measure | Broken Arrow | 95% range | Among the 5 Oklahoma cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 33.6% | 30.5–37.2% | fourth-highest | 2023 |
| Diagnosed diabetes among adults | 9.4% | 8.5–10.5% | fourth-highest | 2023 |
| High blood pressure among adults | 32% | 29.7–34.4% | fourth-highest | 2023 |
| Lack of health insurance among adults aged 18–64 | 9.3% | 8.3–10.5% | third-highest | 2023 |
| Routine checkup in the past year among adults | 75.8% | 73.4–78.4% | tied for lowest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 113,540); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This tirzepatide page is the Broken Arrow entry point to the Oklahoma statewide online listing, not evidence of an office, pharmacy or clinician in Broken Arrow. Each company below appears because its named products have their own Oklahoma evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the Oklahoma guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in Oklahoma, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Broken Arrow, and a listing is not a prescription, appointment or coverage guarantee. Read the Oklahoma Tirzepatide guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's compounded injectable tirzepatide program, if prescribed, billed through its medication-order subscription.
Compounded injectable tirzepatide (injection): 2.5–5 mg/week — $169/mo · >5–10 mg/week — $219/mo · >10–15 mg/week — $269/mo
- Compounded injectable tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
GoodRx Care
GoodRx Care Direct's separately priced branded tirzepatide pen, billed apart from its monthly membership fee.
Zepbound KwikPen (pen): introductory KwikPen strength (page labels it 10 mg) — $338/mo
- Zepbound KwikPen — pen: state evidence checked · Availability source · Full evidence notes
More listings
Other medications for Broken Arrow: GLP-1 medication access · Semaglutide
Tirzepatide in other Oklahoma cities: Edmond · Norman · Oklahoma City · Tulsa
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.